Exai Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 51

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $70.6M

  • Investors
  • 5

Exai Bio General Information

Description

Developer of a liquid biopsy platform designed to accurately diagnose cancer and inform personalized care treatments. The company's platform measures cell-free RNA profiles, analyzing them using advanced artificial intelligence and machine learning algorithms specifically focused on orphan non-coding RNA, small RNA sequences not seen in normal tissue but abundant in tumors, enabling doctors to identify cancer early and accurately and to inform personalized care treatments.

Contact Information

Website
www.exai.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3350 West Bayshore Road
  • Palo Alto, CA 94303
  • United States
Primary Industry
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • 3350 West Bayshore Road
  • Palo Alto, CA 94303
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exai Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 10-Oct-2022 $70.6M Completed Generating Revenue
To view Exai Bio’s complete valuation and funding history, request access »

Exai Bio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-2
Series A-1
To view Exai Bio’s complete cap table history, request access »

Exai Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a liquid biopsy platform designed to accurately diagnose cancer and inform personalized care treatments. Th
Biotechnology
Palo Alto, CA
51 As of 2025

Madison, WI
 

Seattle, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Exai Bio Competitors (25)

One of Exai Bio’s 25 competitors is Exact Sciences, a Formerly VC-backed company based in Madison, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exact Sciences Formerly VC-backed Madison, WI
Parse Biosciences Formerly VC-backed Seattle, WA
Hedera Dx Venture Capital-Backed Epalinges, Switzerland
New England Biolabs Corporation Ipswich, MA
Foundation Medicine Formerly VC-backed Boston, MA
You’re viewing 5 of 25 competitors. Get the full list »

Exai Bio Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 6

    Pending

  • Expiring in next 12 mo

Exai Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026055549-A1 Systems and methods for predicting biomarker expression Pending 06-Sep-2024
WO-2025213080-A2 Systems and methods for detection of non-coding rnas Pending 04-Apr-2024
WO-2025213080-A3 Systems and methods for detection of non-coding rnas Pending 04-Apr-2024
WO-2025014839-A1 Systems and methods for detection of non-coding rnas Inactive 07-Jul-2023
WO-2025006618-A1 Systems and methods for analysis of small rna k-mers Inactive 27-Jun-2023 G06N20/00
To view Exai Bio’s complete patent history, request access »

Exai Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Exai Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Blue Venture Fund Corporate Venture Capital Minority
Casdin Capital Venture Capital Minority
Deviation Capital Venture Capital Minority
Moore Capital Management Hedge Fund Minority
S32 Venture Capital Minority
To view Exai Bio’s complete investors history, request access »

Ready to get started?

Request a free trial

Exai Bio FAQs

  • When was Exai Bio founded?

    Exai Bio was founded in 2021.

  • Where is Exai Bio headquartered?

    Exai Bio is headquartered in Palo Alto, CA.

  • What is the size of Exai Bio?

    Exai Bio has 51 total employees.

  • What industry is Exai Bio in?

    Exai Bio’s primary industry is Biotechnology.

  • Is Exai Bio a private or public company?

    Exai Bio is a Private company.

  • What is the current valuation of Exai Bio?

    The current valuation of Exai Bio is .

  • What is Exai Bio’s current revenue?

    The current revenue for Exai Bio is .

  • How much funding has Exai Bio raised over time?

    Exai Bio has raised $70.6M.

  • Who are Exai Bio’s investors?

    Blue Venture Fund, Casdin Capital, Deviation Capital, Moore Capital Management, and S32 have invested in Exai Bio.

  • Who are Exai Bio’s competitors?

    Exact Sciences, Parse Biosciences, Hedera Dx, New England Biolabs, and Foundation Medicine are some of the 25 competitors of Exai Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process